- Home
- /
- News
- /
- Drug Trials
- /
- August 2009
Drug Trials News for August 2009
Genentech, Inc. announced recently that a Phase III study of Avastin® (bevacizumab) in combination with chemotherapy increased the time that women with metastatic HER2-negative breast cancer whose initial chemotherapy had stopped working lived without the disease worsening (progression-free survival), compared with chemotherapy alone.
27 August, 2009
79% of treatment-naïve HIV-1 infected adults taking once-daily PREZISTA (darunavir) reached an undetectable viral load (the goal of HIV treatment) at week 96, compared to 71% of adults taking lopinavir, the current standard.
19 August, 2009
Biota Holdings Limited has announced successful results from the Asian Phase III clinical trials of CS-8958, its second-generation influenza treatment. CS-8958 has now been assigned the new name of ‘laninamivir’ by the World Health Organization under its International Non-proprietary Names drug identification system.
10 August, 2009
Shire has recently reported positive results from the first of three Phase III studies of velaglucerase alfa, its enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease.
03 August, 2009